October 28, 2020

Volume X, Number 302

William Boudreaux

Bill Boudreaux is an experienced pharmaceutical patent lawyer, bringing more than 20 years of experience from both in-house and private practice settings. Bill’s extensive in-house experience at major pharmaceutical companies gives him a unique perspective, allowing him to provide clients with practical, business-focused advice. He is known for his thoughtful, thorough approach and ability to anticipate client needs.

Bill represents a broad range of biotech and pharma clients ranging from Global Fortune 50 Companies to start-ups.  While at Eli Lilly and Pfizer, he was primary patent counsel for several late-stage and post-launch drug products, including four blockbuster drugs. He has extensive experience in global patent portfolio creation and management, pharmaceutical patent life-cycle planning and IP due diligence. Bill’s experience also includes freedom-to-operate studies, due diligence reviews, infringement/validity studies, and strategy and support for Hatch-Waxman litigation.

Articles in the National Law Review database by William Boudreaux

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Thursday, October 29, 2020
Thursday, October 29, 2020
Thursday, October 29, 2020
Thursday, October 29, 2020
Tuesday, November 10, 2020
Thursday, November 19, 2020
Thursday, December 17, 2020